Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

NOTA:GR

89.970 EUR 0.030 0.03%

As of 02:16:03 ET on 05/07/2015.

Snapshot for Novartis AG (NOTA)

Open: 88.930 Day's Range: 88.923 - 89.970 Volume: 1,449
Previous Close: 90.000 52wk Range: 61.600 - 99.085 1-Yr Rtn: +44.56%

Stock Chart for NOTA

No chart data available.
  • NOTA:GR 89.970
  • 1D
  • 1M
  • 1Y
90.000
Interactive NOTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 19.7188
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 5.1850
Est. PEG Ratio 3.1702
Market Cap (M EUR) 243,476.18
Shares Outstanding (M) 2,706.19
30 Day Average Volume 257
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.65%
Cash Dividend (USD) 2.2586
Dividend Ex-Date 03/02/2015
5 Year Dividend Growth 10.69%
Next Earnings Announcement 07/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NOTA

Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases, oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis, vaccines and diagnostics, vision, and animal health products.

Joseph Jimenez Jr "Joe"Chief Executive OfficerHarry KirschChief Financial Officer
Andre Wyss "Andy"President:SwitzerlandMark C FishmanPresident:Nibr
More Company Profile & Key Executives for NOTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil